Compare Kenvue Inc. Common Stock (KVUE) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs UBS Group AG Registered Ordinary Shares — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while UBS Group AG Registered Ordinary Shares trades at $48.17 (market cap $142.70B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 4.2× Kenvue Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.74%). Which is the better fit depends on your goals.
| KVUE | UBS | |
|---|---|---|
Market Cap | $34.06B | $142.70B |
Volume | 23,267,228 | 2,096,090 |
Sector | Consumer Staples | Financials |
52-Week High | $19.83 | $55.72 |
52-Week Low | $14.11 | $36.41 |
Enterprise Value | $41.56B | $314.41B |
Dividend Yield | 4.74% | 2.34% |
Typical Hold Time | — | 1 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
